SCHEMBL30103064

SCHEMBL30103064

COc1ccc(-c2ccc(CO)cn2)cc1F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP17A1 P05093 1/20 0.50
▸ FYN P06241 5/20 0.49
▸ NPC1 O15118 5/20 0.47
▸ RAB9A P51151 5/20 0.47
▸ SMN1; SMN2 Q16637 4/20 0.47
▸ ALDH1A1 P00352 3/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ PDGFRB P09619 1/20 0.46
▸ PDGFRA P16234 1/20 0.46
▸ TP53 P04637 1/20 0.45
▸ PKM P14618 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ POLB P06746 1/20 0.44
▸ KDM4E B2RXH2 2/20 0.43
▸ GLA P06280 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ KDM1A O60341 1/20 0.43
▸ LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30103063 0.89 KDM1A (0.55) FYNNPC1RAB9ASMN1; SMN2TP53
SCHEMBL30103043 0.89 KDM1A (0.55) FYNNPC1RAB9ASMN1; SMN2TP53
SCHEMBL24785040 0.89 KDM1A (0.55) FYNNPC1RAB9ASMN1; SMN2TP53
SCHEMBL30103108 0.86 CYP17A1 (0.50) CYP17A1NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL24785848 0.86 CYP17A1 (0.50) CYP17A1NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL9806844 0.85 SMN1; SMN2 (0.64) CYP17A1NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL24785367 0.83 PDGFRB (0.51) CYP17A1FYNNPC1RAB9ASMN1; SMN2
SCHEMBL8382053 0.82 CYP11B1 (0.57) CYP17A1FYNNPC1RAB9ASMN1; SMN2
SCHEMBL16440913 0.82 CASP3 (0.64) CYP17A1NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL12987609 0.81 ALDH1A1 (0.52) CYP17A1FYNNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115448913-A Bicyclic compounds for the treatment of EP2, EP4 receptor mediated diseases 武汉人福创新药物研发中心有限公司 2022-12-09 — — CN disclosed
Send feedback